Revisiting TLR9 as a target for CLL therapy. Kortylewski M. Blood 2021;137:3006-3008.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kortylewski M. Revisiting TLR9 as a target for CLL therapy. Blood 2021;137:3006-3008.
PMID: 34081121